SCHEMBL14933653

SCHEMBL14933653

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1n[nH]c2ccc(-c3cc(Cl)ccc3O)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.38
PAK1 Q13153 1/20 0.36
ALOX15 P16050 3/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAP2K4 P45985 2/20 0.36
DYRK1A Q13627 3/20 0.35
ALDH1A1 P00352 2/20 0.35
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
JAK2 O60674 5/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28814551 0.85 PRMT5 (0.34) PAK1MAP2K4DYRK1APRMT5WDR77
SCHEMBL14933629 0.80 FAAH (0.42) PIM1ALOX15MEN1MAPTKMT2A
SCHEMBL14919956 0.77 MAPT (0.32) ALOX15MEN1MAPTKMT2AMAPK1
SCHEMBL16011441 0.77 MAP2K4 (0.39) PAK1MAPTMAP2K4DYRK1APRMT5
SCHEMBL19100167 0.72 KDM4E (0.46) MAPTHPGDMAP2K4ALDH1A1HTT
SCHEMBL29431300 0.72 KDM4E (0.46) MAPTHPGDMAP2K4ALDH1A1HTT
SCHEMBL16021936 0.68 HDAC1 (0.36) ALOX15MEN1MAPTKMT2AMAPK1
SCHEMBL16021942 0.67 FAAH (0.35) KMT2AALDH1A1PDPK1
SCHEMBL19392330 0.67 RECQL (0.34) ALOX15MEN1MAPTKMT2AMAPK1
SCHEMBL16021506 0.67 MAP2K4 (0.40) PAK1MAPTMAPK1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013064984-A1 BIARYL ETHER SULFONAMIDES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2013-05-10 WO disclosed